Features
Get A Demo
Plans
Sign Up
Login
All Federal Contract IDV Awards
Help
Indefinite Delivery Contract HHSN272201400049C
Award Date
9/23/14
Last Date to Order
9/29/19
Overview
🤔 AI Insights
Buyer Personas
Industry Personas
Buyer Personas In this Market
Activity
Contract IDVs
Contract Awards
Transactions
15
Price Lists
Opportunity Stack
5
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
University Of Washington
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
PSC Category
AN11 - Health R&D Services; Health Care Services; Basic Research
Federal Contract Vehicle
Large Scale T-Cell Epitope Discovery
Pricing Type
Cost No Fee
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Large Scale T-Cell Epitope Discovery
Master IDIQ
HHSN272201400049C
Indefinite Delivery Contract
Description
Update #1
LARGE SCALE T CELL EPITOPE DISCOVERY
Posted 9/23/14, 12:00 AM
Mod #
Description
Reason For Modification
Federal Obligation
(Click to sort descending)
Date
(Click to sort ascending)
P00014
LARGE SCALE T CELL EPITOPE DISCOVERY
Close Out
$0
9/21/20
P00013
LARGE SCALE T CELL EPITOPE DISCOVERY
Funding Only Action
($4k)
9/18/20
P00012
LARGE SCALE T CELL EPITOPE DISCOVERY
Funding Only Action
($17k)
9/17/20
11
Change Order
$0
7/13/18
10
Funding Only Action
$1.0m
6/13/18
Name
Description
Solicitation Number
Federal Agency
Type
Posted Date
(Click to sort descending)
Large Scale T Cell Epitope Discovery
Added: Sep 25, 2014 12:51 pm
BAA-NIAID-DAIT-NIHAI2013167
Department of Health and Human Services National Institutes of Health
Award Notice 5/5
9/25/14, 12:51 PM
Large Scale T Cell Epitope Discovery
Added: Sep 25, 2014 12:42 pm
BAA-NIAID-DAIT-NIHAI2013167
Department of Health and Human Services National Institutes of Health
Award Notice 4/5
9/25/14, 12:42 PM
Large Scale T Cell Epitope Discovery
Added: May 16, 2013 9:16 am IntroductionThe National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. The NIAID Division of Allergy, Immunology and Transplantation has a requirement for the discovery of T cell epitopes that are important in protection of humans from infectious diseases, with a focus on NIAID Category A, B, and C Priority Pathogens and other Emerging and Re-Emerging Infectious Diseases.Description The primary purpose of this initiative is to establish multiple highly interactive, multi-disciplinary teams to support large scale discovery of human T cell epitopes associated with protection against microorganisms responsible for emerging and re-emerging infectious diseases and potential agents of bioterrorism and their toxins (listed as NIAID Emerging and Re-Emerging Infectious Diseases at http://www.niaid.nih.gov/topics/emerging/Pages/list.aspx). It is anticipated that the multi-disciplinary teams will minimally include immunologists with the appropriate expertise in epitope identification and validation and microbiologists and/or virologists with expertise in the target pathogen(s). Investigators may include additional pathogens for study that are not listed as NIAID Emerging and Re-Emerging Infectious Diseases. However, pathogens from the NIAID Emerging and Re-Emerging Infectious Diseases list should account for at least 50% of the pathogens in the proposed studies. A list of all pathogens to be studied, and a justification for inclusion of those pathogens not listed as NIAID Emerging and Re-Emerging Diseases shall be provided in the solicitation. This program will not support studies related to HIV/AIDS. Investigators may utilize established technological advances for epitope discovery or develop new or improved technologies for the large-scale identification of novel T cell epitopes. For the purpose of this solicitation, large-scale epitope discovery is defined as methods that will allow for extensive identification and validation of a broad range of novel T cell epitopes. Epitope discovery methods must be accompanied by basic studies in human samples to validate identified epitopes as targets of T cell recognition. Investigators may, but are not required to, include studies in appropriate animal models. Supported investigators will be required to attend an annual program progress meeting at NIH and submit their epitope information, and novel epitope prediction algorithms if applicable, to the Immune Epitope Database and Analysis Resource (www.iedb.org). Solicitations will be evaluated for their scientific and technical merit, scientific and technical personnel, project management plan, and facilities and other resources available to accomplish the proposed studies.It is anticipated that multiple cost reimbursement, completion type contracts will be awarded for a five-year period of performance beginning on or about September 1, 2014.The length of time for which funding is requested should be consistent with the nature and complexity of the proposed research. In no event shall the period of performance proposed by an offeror exceed five (5) years.All responsible sources may submit a proposal which shall be considered by the Agency. This BAA will be available electronically on/about May 31, 2013 and may be accessed through FedBizOpps http://www.fedbizopps.gov/. This notice does not commit the Government to award a contract. No collect calls will be accepted. No facsimile transmissions will be accepted.For this solicitation, the NIAID requires proposals to be submitted via two methods:(1) Disc (CD or DVD) and (2) Online via NIAID electronic Contract Proposal Submission (eCPS) website. The content of the disc and online proposals must be identical. Submission of proposals by facsimile or e-mail are not accepted.For directions on using eCPS, go the website https://ecps.niaid.nih.gov and then click on "How to Submit."To submit online using eCPS, offerors must have a valid NIH electronic Research Administration (eRA) Commons account, which provides authentication and serves as a vehicle for secure transmission of documents and communication with the NIAID. The eRA Commons registration process may take up to 4 weeks. For more information, please see http://era.nih.gov/applicants/ and then click on Registration and Account Creation.
BAA-NIAID-DAIT-NIHAI2013167
Department of Health and Human Services National Institutes of Health
Award Notice 1/5
5/16/13, 9:16 AM
Large Scale T Cell Epitope Discovery
Added: Sep 25, 2014 11:55 am
BAA-NIAID-DAIT-NIHAI2013167
Department of Health and Human Services National Institutes of Health
Award Notice 2/5
9/25/14, 11:55 AM
Large Scale T Cell Epitope Discovery
Added: Sep 25, 2014 12:29 pm
BAA-NIAID-DAIT-NIHAI2013167
Department of Health and Human Services National Institutes of Health
Award Notice 3/5
9/25/14, 12:29 PM